| 000 | 01074cam a2200277 a 4500 | ||
|---|---|---|---|
| 001 | 443293 | ||
| 003 | BD-DhUL | ||
| 005 | 20180205105045.0 | ||
| 008 | 820526s1982 nyua b 101 0 eng | ||
| 010 | _a 82009388 | ||
| 020 | _a0444007245 | ||
| 040 |
_aDLC _cDLC _dDLC _dBD-DhUL |
||
| 082 | 0 | 0 |
_a616.994 _bBAN |
| 111 | 2 |
_aMedicinal Chemistry Symposium _d1981 : _cAmherst, N.Y.) |
|
| 245 | 1 | 0 |
_aNew approaches to the design of antineoplastic agents : _bproceedings of the Twenty-second Annual Medicinal Chemistry Symposium, Amherst, New York, U.S.A., May 18-20, 1981 / _ceditors, Thomas J. Bardos and Thomas I. Kalman. |
| 260 |
_aNew York : _bElsevier Biomedical, _cc1982. |
||
| 300 |
_axxiii, 337 p. : _bill. ; _c24 cm. |
||
| 504 | _aIncludes bibliographical references and indexes. | ||
| 650 | 0 |
_aAntineoplastic agents _xCongresses. |
|
| 650 | 0 |
_aPharmaceutical chemistry _xCongresses. |
|
| 650 | 0 |
_aEnzyme inhibitors _xCongresses. |
|
| 650 | 0 |
_aChemical mutagenesis _xCongresses. |
|
| 700 | 1 | _aBardos, Thomas J. | |
| 700 | 1 | _aKalman, Thomas I. | |
| 942 |
_2ddc _cBK |
||
| 999 |
_c237801 _d237801 |
||